BNGO News and Press, Bionano Genomics Inc.

Bionano, a global leader in the transformation of the cytogenetic workflow with optical genome mapping (OGM), has entered into a strategic partnership with Hangzhou Diagens Biotechnology Co., Ltd. (Diagens), the pioneering leader in artificial intelligence (AI) chromosome karyotype analysis techn...

SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic variations in pediatric B-cell ...

2024-04-04 13:49:53 ET More on Bionano Genomics Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript Bionano Genomics reports Q4 results Bionano Genomics expects Q4 revenue growth of 27% to 30% Seeking Alpha’s Quant Rating on Bionano Genomics...

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 8,733,626 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purcha...

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a peer-reviewed study that compared optical genome mapping (OGM) to classical cytogenetic techniques used for analysis of solid tumor cancer samples consisting of soft tiss...

Nine scientific posters will illustrate the application of optical genome mapping (OGM) in cancer research areas including hematological malignancies, solid tumors, and applications in cell and gene therapy, cell manufacturing and bioprocessing quality control Bionano is introducing...

SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian cancer (HBOC) syndrome showing that when tumors exhibited higher overall numbers of structural varia...

Bionano will host a pre-conference scientific session that will include a live product demonstration of the Stratys™ system for high throughput optical genome mapping (OGM) and findings from early access customers The pre-conference event will also include a 2024 corporate overvi...

2024-03-06 00:30:12 ET Image source: The Motley Fool. Bionano Genomics (NASDAQ: BNGO) Q4 2023 Earnings Call Mar 05, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript

2024-03-05 21:54:02 ET Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Conference Call March 5, 2024 16:30 ET Company Participants David Holmes - Investor Relations Erik Holmlin - Chief Executive Officer Gulsen Kama - Chief Financial Officer Conference Call ...